![]() | ![]() |
||||||
|
|||||||
![]() |
![]() |
Stroke secondary to atherosclerosis (2 Images)
(Doctor-Reviewed information)
Stroke secondary to atherosclerosis refers to loss of neurologic functions (brain attack), which occurs because¿of atherosclerosis. Reviewer: Updated by: A.D.A.M. Editorial Team: Greg Juhn, M.T.P.W., David R. Eltz, Kelli A. Stacy. Previously reviewed by Daniel Kantor, M.D., Director of the Comprehensive MS Center, Neuroscience Institute, University of Florida Health Science Center, Jacksonville, FL. Review provided by VeriMed Healthcare Network. (April 2006)Date: 02/20/2007
Email
| Save
Use Healthline to search the web for more Atherosclerosis information.
How Do You Know If You Have PAD?
Millions of Americans suffer from peripheral arterial disease (PAD), a disease that occurs when your blood cannot flow efficiently through your arteries. F...
Email
| Save
play video
read transcript
What is Peripheral Arterial Disease?
Peripheral arterial disease (PAD) is a blockage of arteries in the extremities, which can cause cramping in the legs, hips and thighs. Tune in to learn mor...
Email
| Save
play video
read transcript
Trans Fats on the Brain
"By Peter Jaret, EatingWell.com"
First came warnings that trans fatsthe artificially produced fats used in margarine and many processed foodsappear to be even worse than saturated fat when it comes to clogging arteries. Now comes word that these same fats may gum up our brains too.
Cholesterol In The News: Answers And More Questions
MediLexicon | 3 days ago
Understanding cholesterol is more than figuring out what's good and bad. Although much is known about this waxy substance that's in all body cells and its relationship with heart disease, much is still ...
Abbott Laboratories and AstraZeneca PLC Expand Relationship to Include Co-Promotion of CRESTOR
BioSpace | 24 days ago
Abbott and AstraZeneca announced today that they have entered into an agreement for Abbott to promote AstraZeneca's CRESTOR , a medication used along with diet to reduce high cholesterol.
Wyeth extends partnership with Swedish firm
The Jersey Journal | 24 days ago
Wyeth today extended a partnership with drug developer Karo Bio of Sweden, through which the companies collaborate to develop drugs to treat the artery disease atherosclerosis.